Drug Shortage Report for TWINRIX

Last updated on 2017-07-19 History
Report ID 11383
Drug Identification Number 02230578
Brand name TWINRIX
Common or Proper name Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN
Strength(s) 720UNIT 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-05-24
Estimated end date 2017-07-11
Actual end date 2017-07-10
Shortage status Resolved
Updated date 2017-07-19
Company comments Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-07-19 French Compare
v7 2017-07-19 English Compare
v6 2017-07-11 French Compare
v5 2017-07-11 English Compare
v4 2017-06-28 French Compare
v3 2017-06-28 English Compare
v2 2017-05-26 French Compare
v1 2017-05-26 English Compare